Uncategorized
What 4 Analyst Ratings Have To Say About Protagonist Therapeutics
Latest Ratings for PTGX Date Firm Action From To Feb 2022 BTIG Initiates Coverage On Buy Nov 2021 JMP Securities Maintains Market Outperform Oct 2021 JMP Securities Maintains Market Outperform View More Analyst Ratings for PTGX View the Latest Analyst Ratings read more
Ralph Lauren Flags Weak Macro Visibility, Maintains Cautious Outlook
Ralph Lauren stock fell despite strong Q1 fiscal 2026 results, with revenue up 14% and GAAP net income of $3.52/share. Growth expected in all regions. read more
Zimmer Biomet’s $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum. read more
Why Is Celsius Holdings Stock Gaining Today?
Celsius Holdings shares are trading higher as the Q2 earnings per share and sales crush forecasts, doubled EBITDA, and robust global growth. read more
Inspire Medical Stock Strays Off Course Amid Structural Setback
Inspire Medical’s chart structure signals weakness after a major breakdown. Here’s why investors may want to avoid the stock until 2028. read more